FDA Attempts to Reign in BIG PHARMA Corruption, Larger COI Problems, Corruption Remain Unaddressed

Medical expert and someone very familiar with the FDA, Dr Peter McCullough™ told Grant Stinchfield that recent agency efforts to curb influence from pharmaceutical companies amounts to window dressing. Nine of the last ten commissioners have taken board positions or jobs with BIG PHARMA or their investors after currying favor while in office. The new FDA staff with no regulator experience are even more at risk and appear to be on the same track after rubber stamping more COVID-19 boosters with no human data whatsoever. Courtesy Stinchfield Tonight, April 22, 2025.